Davide Charrier

Dr. Davide Charrier

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
DCDavide Charrier
Davide Charrier
Giuseppe CerulloGiuseppe Cerullo
Giuseppe Cerullo
RCRoberta Carpenito
Roberta Carpenito
VVVincenzo Vindigni
Vincenzo Vindigni
Franco BassettoFranco Bassetto
Franco Bassetto
Antonio PaoliAntonio Paoli
Antonio Paoli
Obesity is defined as a complex, systemic disease characterized by excessive and dysfunctional adipose tissue, leading to adverse health effects. This condition is marked by low-grade inflammation, oxidative stress, and metabolic abnormalities, including mitochondrial dysfunction. These factors promote energy dysregulation and impact body composition not only by increasing body fat but also by promoting skeletal muscle mass atrophy. The decline in muscle mass is associated with an increased risk of all-cause mortality in individuals with this disease. The European Food Safety Authority approved pyrroloquinoline quinone (PQQ), a natural compound, as a dietary supplement in 2018. This narrative review aims to provide a comprehensive overview of the potential role of PQQ, based on its anti-inflammatory and antioxidant properties, in addressing dysfunctional adipose tissue metabolism and related disorders.